Telix Pharmaceuticals Limited (TLX)
(Real Time Quote from BATS)
$11.77 USD
-0.20 (-1.67%)
Updated Aug 7, 2025 03:40 PM ET
After-Market: $11.77 0.00 (0.00%) 4:08 PM ET
4-Sell of 5 4
D Value B Growth A Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, Telix Pharmaceuticals Limited has a market cap of $4.05B, which represents its share price of $11.97 multiplied by its outstanding shares number of 338.40M. As a mid-cap company, TLX's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
TLX 11.77 -0.20(-1.67%)
Will TLX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TLX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TLX
All You Need to Know About Telix Pharmaceuticals Limited (TLX) Rating Upgrade to Buy
Telix Shares May Gain on the Distribution Deal With Cardinal Health
TLX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Telix Pharmaceuticals Limited (TLX) Upgraded to Buy: What Does It Mean for the Stock?
What Makes Telix Pharmaceuticals Limited (TLX) a Good Fit for 'Trend Investing'
Other News for TLX
Telix Pharmaceuticals: Assessing The Market's Pullback On SEC Inquiry
Telix H1 2025 Results: Investor Webcast Notification | TLX Stock News
Telix Pharmaceuticals Faces SEC Investigation: Shares Plummet | TLX stock news
12 Health Care Stocks Moving In Wednesday's Intraday Session
First Look: Abivax Soars, Apple and Google Face UK Probe